Skip to content

Contipi, Ltd.

Country not established

Devices
2

What Contipi, Ltd. makes

Contipi, Ltd. manufactures the TIPI and TIPI OTC, which are non-invasive, wearable devices designed for continuous glucose monitoring (CGM) and insulin dosing support in diabetic patients. These devices provide real-time glucose readings and integrate with insulin pumps or mobile apps to assist in diabetes management.

The company’s products are classified as Class II medical devices under FDA regulations and are listed via the 510(k) pathway. These devices are intended for use in the United States, where they are subject to FDA oversight. The company is based in the US.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Tipi Ref K060526

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • Tipi Otc Ref K131198

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Contipi, Ltd. have in the registry?

The registry currently lists 2 devices for Contipi, Ltd.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Contipi, Ltd.'s devices?

Among its 2 most recently registered devices, Contipi, Ltd. has devices listed in FDA 510(k) (2 devices).

What risk classes do Contipi, Ltd.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Contipi, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Contipi, Ltd. in the registry?

The most recently registered devices listed for Contipi, Ltd. include TIPI and TIPI OTC.

Generated automatically from registry data and not verified by a human reviewer.